paclitaxel has been researched along with Degenerative Diseases, Central Nervous System in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (62.50) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Ballatore, C; Deiches, RF; Huryn, D; Hyde, E; Lee, VM; Smith, AB; Trojanowski, JQ | 1 |
| Lanjanian, H; Pejman, S; Pooyan, S; Riazi, G | 1 |
| Cascini, GL; Evangelista, L; Luigi, M | 1 |
| Feinstein, SC; Guzman, E; LaPointe, NE; Pessino, V; Valentine, MT; Wilson, L; Yu, D | 1 |
| Ovádi, J | 1 |
| Ballatore, C; Lee, VM; Smith, AB; Trojanowski, JQ; Zhang, B | 1 |
| Audus, KL; Georg, G; Liu, Y; Michaelis, ML; Rice, A; Turunen, B | 1 |
| Huryn, D; Lee, VM; Smith, AB; Trojanowski, JQ | 1 |
1 review(s) available for paclitaxel and Degenerative Diseases, Central Nervous System
| Article | Year |
|---|---|
New issues for copper-64: from precursor to innovative PET tracers in clinical oncology.
Topics: Breast Neoplasms; Cell Line, Tumor; Cisplatin; Copper Radioisotopes; Drug Resistance, Neoplasm; Female; Homeostasis; Humans; Male; Neurodegenerative Diseases; Paclitaxel; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals | 2013 |
7 other study(ies) available for paclitaxel and Degenerative Diseases, Central Nervous System
| Article | Year |
|---|---|
Paclitaxel C-10 carbamates: potential candidates for the treatment of neurodegenerative tauopathies.
Topics: Animals; Blood-Brain Barrier; Brain; Carbamates; Chemistry, Pharmaceutical; Drug Design; Humans; Mice; Models, Chemical; Neurodegenerative Diseases; Paclitaxel; Permeability; Tauopathies; Time Factors | 2007 |
Peptide LIQ Promotes Cell Protection against Zinc-Induced Cytotoxicity through Microtubule Stabilization.
Topics: Animals; Cytoprotection; Microtubule-Associated Proteins; Microtubules; Mitochondrial Proteins; Neurodegenerative Diseases; Neuroprotection; Paclitaxel; Rats, Wistar; Tubulin; Zinc | 2020 |
Tau proteins harboring neurodegeneration-linked mutations impair kinesin translocation in vitro.
Topics: Animals; Brain; Cattle; Humans; Kinesins; Microtubules; Mutation; Neurodegenerative Diseases; Paclitaxel; Protein Isoforms; Quantum Dots; tau Proteins; Tubulin; Tubulin Modulators | 2014 |
The tubulin polymerization promoting protein, TPPP/p25.
Topics: Animals; Brain; Brain Chemistry; Humans; Microtubules; Nerve Tissue Proteins; Neurodegenerative Diseases; Paclitaxel; Research; Tubulin; Tubulin Modulators | 2008 |
In situ blood-brain barrier permeability of a C-10 paclitaxel carbamate.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blood-Brain Barrier; Brain; Carbamates; Central Nervous System; Disease Models, Animal; Mice; Molecular Structure; Neurodegenerative Diseases; Paclitaxel; Permeability; Structure-Activity Relationship | 2008 |
Overcoming the blood-brain barrier to taxane delivery for neurodegenerative diseases and brain tumors.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Binding Sites; Blood-Brain Barrier; Brain Neoplasms; Cells, Cultured; Dose-Response Relationship, Drug; Drug Delivery Systems; Drug Design; Endothelial Cells; Male; Microtubules; Molecular Conformation; Neurodegenerative Diseases; Neurofibrillary Tangles; Paclitaxel; Rats; Rats, Sprague-Dawley; Rhodamine 123; Succinic Acid; Taxoids | 2003 |
Microtubule-stabilising drugs for therapy of Alzheimer's disease and other neurodegenerative disorders with axonal transport impairments.
Topics: Alzheimer Disease; Animals; Axonal Transport; Humans; Microtubules; Neurodegenerative Diseases; Paclitaxel | 2005 |